Literature DB >> 892367

The liver during and after fulminant hepatitis.

J T Horney, J T Galambos.   

Abstract

Within 5 to 14 days of onset of grade 3 or 4 coma, liver biopsies were obtained in 14 of 15 consecutive patients who recovered from fulminant hepatitis. In 9 patients, follow-up biopsy was obtained 6 to 60 months after acute hepatitis and autopsy was performed in 2 patients who died in 4 months from complications of hepatitis (aplastic anemia) or of corticosteroid therapy (sepsis). During fulminant illness the biopsy findings were: multilobular necrosis in 4 patients, confluent (bridging) necrosis in 9, and only portal inflammation in 1. The duration or the grade of coma did not correlate with the severity of necrosis on the biopsy. Follow-up biopsy showed development of chronic (active) hepatitis in 3 of 9 patients (with cirrhosis in one of these). Chronic liver disease was not found in the two autopsies. If fulminant hepatitis is the result of vigorous cell-mediated immune attack on hepatocytes, then this process cannot always eradicate chronic hepatitis B surface antigenemia, nor can it always prevent the development of chronic (active) hepatitis or cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892367

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  18 in total

1.  Postoperative imaging findings in children with auxiliary partial orthotopic liver transplant (APOLT).

Authors:  Rama S Ayyala; Mercedes Martinez; Steven J Lobritto; Tomoaki Kato; Carrie Ruzal-Shapiro
Journal:  Pediatr Radiol       Date:  2016-02-11

Review 2.  Fulminant hepatic failure.

Authors:  R J Yanda
Journal:  West J Med       Date:  1988-11

3.  A fulminant hepatitis associated with acute renal failure: an indication for hemodialysis and hemoperfusion.

Authors:  T Shinoda; H Hayashi; S Kakumu; J Rhyuge; H Kawahara; T Ohokura; N Sakamoto
Journal:  Gastroenterol Jpn       Date:  1979

4.  Auxiliary partial orthotopic liver transplantation for fulminant hepatitis. The Paul Brousse experience.

Authors:  H Bismuth; D Azoulay; D Samuel; M Reynes; G Grimon; P Majno; D Castaing
Journal:  Ann Surg       Date:  1996-12       Impact factor: 12.969

5.  Fulminant hepatic failure and artificial liver support.

Authors:  A E Gimson; R Ede; S Braude; R D Hughes; P J Langley; R Williams
Journal:  Gastroenterol Jpn       Date:  1982-04

6.  Fulminant hepatic failure in childhood: an analysis of 31 cases.

Authors:  H T Psacharopoulos; A P Mowat; M Davies; B Portmann; D B Silk; R Williams
Journal:  Arch Dis Child       Date:  1980-04       Impact factor: 3.791

7.  Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound.

Authors:  Katsuaki Tanaka; Kazushi Numata; Manabu Morimoto; Kazuhito Shirato; Satoru Saito; Toshio Imada; Shinju Arata; Mitsugi Sugiyama
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

8.  Prediction of hepatic encephalopathy development in patients with severe acute hepatitis.

Authors:  Yasuhiro Takikawa; Ryujin Endo; Kazuyuki Suzuki; Kenji Fujiwara; Masao Omata
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

9.  Histopatological findings of the liver before and during hepatic coma in fulminant hepatitis.

Authors:  M Shimizu; T Yoshida; H Ohnishi; E Tomita; Y Muto; Y Takahashi
Journal:  Gastroenterol Jpn       Date:  1982

10.  Azathioprine treatment in a patient with HBsAg-positive acute viral hepatitis complicated by bridging necrosis.

Authors:  E Sagnelli; F M Felaco; G Pasquale; P Filippini; F Piccinino
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.